Intranasal dexmedetomidine for adrenergic crisis in familial dysautonomia.

Christy L SpalinkErin BarnesJose Alberto PalmaLucy Norcliffe-KaufmannHoracio Kaufmann

Published in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society (2017)

Intranasal dexmedetomidine is a feasible and safe acute treatment for adrenergic crisis in patients with familial dysautonomia. Further controlled studies are required to confirm the safety and efficacy in this population.

Keyphrases

public health
cardiac surgery
early onset
liver failure
respiratory failure
drug induced
acute kidney injury
intensive care unit
case control
extracorporeal membrane oxygenation
mechanical ventilation